PBN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alterity Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.312 EUR -1.89% Market Closed

Market Cap: €8B

	Alterity Therapeutics Ltd F:PBN	AU
	Bluechiip Ltd F:1BL	AU
	Teco 2030 ASA F:TE9	NO
	Repsol SA MAD:REP	ES
C	Cara Therapeutics Inc F:69C	US
	Yojee Ltd F:SRC	AU

Profitability Summary

Alterity Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 337%

Negative 3Y Average Operating Margin

-6 184%

Operating Margin is Increasing

-89 157% > -1 337%

Negative Net Margin

-1 172%

Negative 3Y Average Net Margin

-5 707%

Net Margin is Increasing

-84 186% > -1 172%

Negative Free Cash Flow Margin

-1 773%

Negative 3Y Average Free Cash Flow Margin

-5 140%

Free Cash Flow Margin is Increasing

-122 214% > -1 773%

Negative ROE

-47%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-327%

Declining ROIC

-310% > -333%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.